Biomarkers Market Size, Share & Trends Report

Biomarkers Market Size, Share & Trends Analysis Report By Type (Efficacy, Validation), By Product, By Application (Drug Discovery & Development, Personalized Medicine), By Disease, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-979-1
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the biomarkers market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for biomarkers market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of biomarkers market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Biomarkers Market Categorization:

The biomarkers market was categorized into four segments, namely type (Safety, Efficacy, Validation), application (Diagnostics, Drug discovery & development, Personalized Medicine), disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The biomarkers market was segmented into type, application, disease, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The biomarkers market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; India; China; Japan; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; UAE; South Africa; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

biomarkers market companies & financials:

The biomarkers market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • F. Hoffmann-La Roche Ltd., F. Hoffmann-La Roche Ltd. is a healthcare company with business operations in the following divisions—pharmaceuticals and diagnostics. It was incorporated in 1896 and is headquartered in Switzerland. Roche Diagnostics comprises Roche Professional Diagnostics (RPD), Roche Molecular Diagnostics (RMD), Roche Tissue Diagnostics, and Roche Diabetes Care. The product portfolio of Roche Diagnostics includes blood glucose meters, point-of-care testing devices, high-throughput analyzers for commercial & hospital diagnostic laboratories, and reagents & instruments for life sciences research. RMD, a segment of Roche Diagnostics, is engaged in the development, manufacture, and distribution of tests based on PCR technology & medical diagnostic products, platforms, and services. RMD’s automated platforms and diagnostic tests focus on areas, such as virology, genomics & oncology, blood screening tests, Human Papillomavirus (HPV) & Neisseria gonorrhea/Chlamydia trachomatis, and microbiology.

  • Abbott, Abbott has four core business segments—pharmaceuticals, devices, nutrition, and diagnostics. It was incorporated in 1888 and is headquartered in the U.S. The company has a presence in more than 150 countries with research, manufacturing, sales, and distribution facilities. Abbott’s pharmaceuticals segment offers generic medicines for pain, fever, migraine, inflammation, pancreatic disorders, & hypertension; cardiovascular & metabolic products; and vaccines. The diagnostic segment offers reagents and tests for various applications. The company’s diagnostics portfolio includes technologies such as polymerase chain reaction, fluorescence in situ hybridization, and DNA & RNA sequencing. Abbott’s immunoassays and clinical chemistry assays are used in the diagnosis of cancer, infectious diseases, cardiovascular diseases, fertility, and therapeutic drug monitoring. It employs over 109,000 people globally.

  • Epigenomics AG, Epigenomics AG is a molecular diagnostic company headquartered in Berlin, Germany. It was established in 1998. Epigenomics AG is engaged in the development and commercialization of diagnostic tests for cancer screening, diagnosis, and patient management. Some of the key products in the company’s portfolio are Epi proColon and Epi proLung—diagnostic tests for colorectal cancer and lung cancer, respectively. In addition, the company has identified additional DNA methylation biomarkers via R&D for different cancers, including prostate, breast, bladder, and ovarian cancers. The company employs 33 people.

  • General Electric, GE Healthcare Company operates as a subsidiary of General Electric (GE) Company. It was established in 1892 and is headquartered in Chicago, U.S. The company offers medical technologies and solutions to healthcare entities worldwide. The company specializes in cardiology, orthopedics, and ambulatory surgery centers. It offers products for bone health, EP recording, clinical parameters, accessories, computed tomography, advanced visualization, diagnostic cardiology, hemodynamic recording, metabolic health, patient monitoring, healthcare IT, mammography, interventional image-guided systems, life sciences, perioperative care, radiography, fluoroscopy, magnetic resonance imaging, molecular imaging, nuclear imaging agents, perinatal care, respiratory care, surgical imaging, and ultrasound. The company was formerly known as GE Medical Systems and changed its name to GE Healthcare Limited in October 2003. The company had an employee strength of approximately 168,000 as of 2021.

  • Johnson & Johnson Services, Inc., Johnson & Johnson Services, Inc. is dedicated to developing products related to human health and well-being. It was incorporated in 1886 and is headquartered in the U.S. The company has more than 250 operating units in more than 60 countries. It operates via three business units: consumer healthcare, pharmaceuticals, and medical devices. The consumer healthcare business unit has seven key franchises—nutritional products, skin & hair care, wound care, topical and over-the-counter drugs, oral health care, women’s health, and baby care. Janssen Pharmaceuticals, Inc.—a subsidiary of the company—is involved in the production of pharmaceutical and consumer products. The pharmaceuticals division consists of an array of drugs for neurological conditions, cancer, pain, and autoimmune diseases. As of December 2021, the company employs over 141,700 people globally.

  • Thermo Fisher Scientific, Inc., Thermo Fisher Scientific, Inc. manufactures and supplies scientific equipment, analytical instruments, and other laboratory equipment worldwide. It was incorporated in 1956 and is headquartered in the U.S. The company’s operations are divided into the following sections: pharmaceutical & biotechnology, industrial & applied research, diagnostics & healthcare, and academic & government. It provides chromatographs, Erlenmeyer flasks, gene sequencers & spectrometers, clinical analytical tools, and diagnostic testing products. The company serves more than 400,000 customers globally through its various brands, including Applied Biosystem, Fisher Scientific, Thermo Scientific, Unity Lab Services, and Invitrogen. Its major products include molecular biology reagents, instruments, antibodies, protein biology reagents, and cell imaging & analysis instruments. As of December 2021, the company has an employee strength of 130,000.

  • Bio-Rad Laboratories, Inc., Bio-Rad Laboratories, Inc. manufactures systems and products used in separating complex biological and chemical materials as well as analyzing, identifying, and purifying their respective components. It was incorporated in 1952 and is headquartered in the U.S. The company works in two segments: clinical diagnostics and life sciences. In the clinical diagnostics segment, it designs, manufactures, supports, and sells informatics systems, test systems, quality controls, and test kits. These products serve clinical laboratories in the global market. Similarly, the life sciences segment is employed in the creation and discovery of tools required in biological processes. The company manufactures reagents, apparatus, and laboratory instruments used in the process of biopharmaceutical production, research techniques, & food testing regimes. The company’s products have main applications in hospitals, research institutions, laboratories, biotechnology companies, and pharmaceutical firms. The company has direct distribution channels in approximately 35 countries. The company has an employee strength of approximately 7,900 (as of December 2021).

  • Siemens Healthineers AG, Siemens Healthineers AG is a provider of healthcare solutions such as diagnostics (in vitro & in vivo), imaging & therapy systems, clinical products, audiology solutions, and healthcare IT solutions. The company was founded as a separate entity in 2015. It also offers medical accessories, OEM component & medical electronics solutions, refurbished systems for medical imaging & therapy, technical, maintenance, and professional & consulting services. Its products and solutions are used in various areas, including therapeutic drug monitoring cardiology, organ transplant, urology, infectious disease, diabetes, women's health, surgery, oncology, neurology, and growth disorders. The company has around 18,500 patents worldwide in over 70 countries. It employs over 66,000 employees globally.

  • Qiagen, QIAGEN is a holding company that caters to the biotechnology industry. It was incorporated in 1984 and is headquartered in Germany. The company provides samples and assay technologies for academic research, applied testing, molecular diagnostics, and pharmaceutical research. It markets over 500 products, including consumable kits and automation systems. Its products for molecular diagnostics cover relevant areas of healthcare, ranging from early diagnosis of diseases to establishment of diagnosis to diagnostic testing for determination of suitable treatment to point-of-need testing. The company’s customers include healthcare providers, pharmaceutical & biotechnology companies, government or industrial customers, and researchers. The company employs 5,200 employees globally.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Biomarkers Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Biomarkers Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon